Experience of women on the Irish National Gestational Trophoblastic Disease Registry
- PMID: 35367922
- DOI: 10.1016/j.ejogrb.2022.03.039
Experience of women on the Irish National Gestational Trophoblastic Disease Registry
Abstract
Objective: Gestational Trophoblastic Disease (GTD) is a rare pregnancy related disorder and the most curable of all gynaecological malignancies. GTD comprises the premalignant conditions of complete or partial hydatidiform mole known as molar pregnancy and a spectrum of malignant disorders termed gestational trophoblastic neoplasia. Clinical management and treatment in specialist centres is essential to achieve high cure rates and clinical guidelines recommend registration with a GTD centre as a minimum standard of care. National GTD registries are valuable repositories of epidemiological data and facilitate clinical audit, centralised pathology review and human chorionic gonadotropin (hCG) monitoring. This study sought the opinion of women enrolled on the Irish National GTD registry to inform future service development and establish a knowledge base for molar pregnancy in Ireland.
Study design: A cross-sectional survey using an anonymised questionnaire was distributed by post to all women on the GTD registry. The questionnaire was designed by a multidisciplinary team and consisted of twenty-five closed-ended questions and two open-ended questions to facilitate feedback. Data collected in the survey included information on the patient experience of registration, knowledge of molar pregnancy, diagnosis at their local hospital, hCG monitoring and overall satisfaction with the service.
Results: The survey had a successful participation rate of 42.6% (215/504). Forty-nine percent (n = 106) of respondents rated a rapid hCG result as their top priority. Forty percent (n = 84) of women had concerns about future pregnancies but acknowledged that these were largely addressed by the GTD specialist nurses. A quarter of respondents reported that other medical professionals with whom they interacted during follow-up treatment did not understand their condition. Many women commented on the emotional stress of attending their local maternity unit for phlebotomy while dealing with pregnancy loss.
Conclusion: This study is unique in being the first survey of women on the Irish National GTD registry. It highlights the specific needs of women with molar pregnancy in terms of psychological support, bereavement counselling and peer support groups. It reveals a knowledge gap in molar pregnancy amongst healthcare professionals which should be considered in future planning of medical and nursing curricula.
Keywords: Gestational Trophoblastic Disease; Human chorionic gonadotrophin; Molar pregnancy; Pregnancy loss.
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.Am J Obstet Gynecol. 2021 Oct;225(4):401.e1-401.e9. doi: 10.1016/j.ajog.2021.05.006. Epub 2021 May 18. Am J Obstet Gynecol. 2021. PMID: 34019886
-
Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis.Am J Obstet Gynecol. 2021 Nov;225(5):513.e1-513.e19. doi: 10.1016/j.ajog.2021.05.031. Epub 2021 May 29. Am J Obstet Gynecol. 2021. PMID: 34058170 Free PMC article.
-
Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients.Am J Obstet Gynecol. 2024 Mar;230(3):362.e1-362.e8. doi: 10.1016/j.ajog.2023.09.006. Epub 2023 Sep 16. Am J Obstet Gynecol. 2024. PMID: 37722570
-
Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.Obstet Gynecol. 2020 Jan;135(1):12-23. doi: 10.1097/AOG.0000000000003566. Obstet Gynecol. 2020. PMID: 31809433 Free PMC article.
-
Advances in diagnostics and management of gestational trophoblastic disease.Radiol Oncol. 2022 Oct 27;56(4):430-439. doi: 10.2478/raon-2022-0038. eCollection 2022 Dec 1. Radiol Oncol. 2022. PMID: 36286620 Free PMC article. Review.
Cited by
-
Association of gestational trophoblastic disease with subsequent development of non-trophoblastic cancer.Int J Gynaecol Obstet. 2025 Mar;168(3):1305-1311. doi: 10.1002/ijgo.15976. Epub 2024 Oct 19. Int J Gynaecol Obstet. 2025. PMID: 39425609 Free PMC article.
-
Workplace supports for early pregnancy loss: A scoping review of international literature.Work. 2025 May;81(1):2021-2047. doi: 10.1177/10519815241305007. Epub 2025 Jan 16. Work. 2025. PMID: 39973636 Free PMC article.
-
Advances in the diagnosis and early management of gestational trophoblastic disease.BMJ Med. 2022 Dec 16;1(1):e000321. doi: 10.1136/bmjmed-2022-000321. eCollection 2022. BMJ Med. 2022. PMID: 36936581 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous